Artiva Biotherapeutics, Inc. (ARTV)

Latest Insider Confidence Score

2026Q1

53.0
Bullish

Company insider confidence (by quarter)

2024Q3 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Aslan Fred CEO 343,999 Nov 17, 2025
Schwab Andrew J. 10% Owner 214,692 Jul 24, 2024
Parmar Kush 10% Owner 214,692 Jul 24, 2024
5am Partners VI, Llc 10% Owner 214,692 Jul 24, 2024
5am Ventures VI, L.P. 10% Owner 214,692 Jul 24, 2024

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 24, 2026 Huston Thad Allen CFO Neutral 52.5 - 0.00% -
Feb 18, 2026 Feb 19, 2026 Sorg Elaine K. Director Neutral 52.5 - 0.00% -
Feb 19, 2026 Sorg Elaine K. Director Neutral 52.5 - 0.00% -
Feb 15, 2026 Feb 18, 2026 Raymon Heather SVP, Research and Development Sell 90.0 +44,479 41.63% $6.1K
Feb 15, 2026 Feb 18, 2026 Horan Christopher Chief Tech Operations Officer Sell 90.0 +115,113 62.11% $8.7K
Feb 15, 2026 Feb 18, 2026 Bush Jennifer COO Sell 91.3 +113,785 48.85% $14.1K
Feb 15, 2026 Feb 18, 2026 Banerjee Subhashis Chief Medical Officer Neutral 90.0 +102,000 204.00% -
Feb 15, 2026 Feb 18, 2026 Aslan Fred CEO Sell 95.0 +352,250 29.11% $58.4K
Dec 15, 2025 Dec 15, 2025 Aslan Fred CEO Sell 52.5 -3,187 -0.26% $19.1K
Dec 12, 2025 Dec 12, 2025 Raymon Heather SVP, Research and Development Neutral 90.0 +67,253 169.87% -
Dec 12, 2025 Dec 12, 2025 Horan Christopher Chief Tech Operations Officer Neutral 90.0 +107,156 137.06% -
Dec 12, 2025 Dec 12, 2025 Bush Jennifer COO Neutral 90.0 +84,877 57.33% -
Dec 12, 2025 Dec 12, 2025 Aslan Fred CEO Neutral 90.0 +869,136 252.66% -
Nov 15, 2025 Nov 17, 2025 Raymon Heather SVP, Research and Development Sell 27.5 -1,375 -3.36% $4.5K
Nov 15, 2025 Nov 17, 2025 Horan Christopher Chief Tech Operations Officer Sell 27.5 -1,899 -2.37% $6.2K
Nov 15, 2025 Nov 17, 2025 Bush Jennifer COO Sell 27.5 -3,055 -2.02% $9.9K
Nov 15, 2025 Nov 17, 2025 Krishnamohan Neha CFO Sell 26.3 -3,490 -3.39% $11.3K
Nov 15, 2025 Nov 17, 2025 Aslan Fred CEO Sell 41.3 -12,722 -3.57% $42.1K
Oct 17, 2025 Oct 17, 2025 Aslan Fred CEO Sell 32.5 -25,500 -6.67% $153K
May 15, 2025 Aug 18, 2025 Aslan Fred CEO Sell 28.8 -34,444 -8.27% $91.4K
May 15, 2025 Aug 18, 2025 Raymon Heather SVP, Research and Development Sell 27.5 -2,384 -5.50% $6.1K
May 15, 2025 Aug 18, 2025 Krishnamohan Neha CFO Sell 26.3 -7,154 -6.50% $18.8K
May 15, 2025 Aug 18, 2025 Bush Jennifer COO Sell 26.3 -8,346 -5.23% $21.8K
May 15, 2025 Aug 18, 2025 Horan Christopher Chief Tech Operations Officer Sell 26.3 -4,918 -5.79% $12.7K
Jun 24, 2025 Jun 26, 2025 RA CAPITAL MANAGEMENT, L.P. Director Neutral 52.5 - 0.00% -
Jun 24, 2025 Jun 26, 2025 MOORE ALISON Director Neutral 52.5 - 0.00% -
Jun 24, 2025 Jun 26, 2025 Baker Daniel G. Director Neutral 52.5 - 0.00% -
Jun 24, 2025 Jun 26, 2025 HOUGEN ELIZABETH L Director Neutral 52.5 - 0.00% -
Jun 24, 2025 Jun 26, 2025 Stoppel Laura Director Neutral 52.5 - 0.00% -
Jun 24, 2025 Jun 26, 2025 Miralles Gines Diego Director Neutral 52.5 - 0.00% -
Jun 24, 2025 Jun 26, 2025 DANIELS BRIAN Director Neutral 52.5 - 0.00% -
Apr 8, 2025 Apr 25, 2025 Banerjee Subhashis Chief Medical Officer Neutral 90.0 +50,000 100.00% -
Apr 25, 2025 Banerjee Subhashis Chief Medical Officer Neutral 52.5 - 0.00% -
Mar 5, 2025 Mar 7, 2025 Aslan Fred CEO Neutral 90.0 +200,000 92.31% -
Feb 26, 2025 Feb 28, 2025 Raymon Heather SVP, Research and Development Neutral 90.0 +33,350 333.50% -
Feb 26, 2025 Feb 28, 2025 Graef Thorsten Chief Medical Officer Neutral 90.0 +60,000 300.00% -
Feb 26, 2025 Feb 28, 2025 Horan Christopher Chief Tech Operations Officer Neutral 90.0 +60,000 240.00% -
Feb 26, 2025 Feb 28, 2025 Krishnamohan Neha CFO Neutral 90.0 +60,000 120.00% -
Feb 26, 2025 Feb 28, 2025 Bush Jennifer COO Neutral 90.0 +86,650 119.03% -
Jan 28, 2025 Jan 29, 2025 Baker Daniel G. Director Neutral 52.5 - 0.00% -
Jan 29, 2025 Baker Daniel G. Director Neutral 52.5 - 0.00% -
Oct 21, 2024 Oct 22, 2024 MOORE ALISON Director Neutral 52.5 - 0.00% -
Oct 22, 2024 MOORE ALISON Director Neutral 52.5 - 0.00% -
Sep 12, 2024 Sep 13, 2024 Raymon Heather SVP, Research and Development Neutral 90.0 +10,000 100.00% -
Sep 12, 2024 Sep 13, 2024 Graef Thorsten Chief Medical Officer Neutral 90.0 +20,000 100.00% -
Sep 12, 2024 Sep 13, 2024 Horan Christopher Chief Tech Operations Officer Neutral 90.0 +25,000 100.00% -
Sep 12, 2024 Sep 13, 2024 Krishnamohan Neha CFO Neutral 90.0 +50,000 100.00% -
Sep 12, 2024 Sep 13, 2024 Bush Jennifer COO Neutral 90.0 +50,000 219.31% -
Jul 22, 2024 Jul 24, 2024 RA CAPITAL MANAGEMENT, L.P. Director Buy 100.0 +8,795,020 459.88% $104.7M
Jul 22, 2024 Jul 24, 2024 5AM Partners VI, LLC 10% Owner Buy 100.0 +1,295,020 122.37% $14.7M
Jul 22, 2024 Jul 22, 2024 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner Buy 97.5 +49,019 33.79% $500K
Jul 22, 2024 Jul 22, 2024 venBio Global Strategic Fund III, L.P. 10% Owner Buy 100.0 +878,353 83.00% $5M
Jul 22, 2024 Jul 22, 2024 GC Corp. 10% Owner Buy 100.0 +2,633,765 136.21% $30.6M
Jul 22, 2024 Jul 22, 2024 Huh Yong-Jun Director Buy 100.0 +2,633,765 136.21% $30.6M
Jul 22, 2024 Jul 22, 2024 Aslan Fred CEO Neutral 90.0 +228,905 100.00% -
Jul 18, 2024 venBio Global Strategic Fund III, L.P. 10% Owner Neutral 52.5 - 0.00% -
Jul 18, 2024 RA CAPITAL MANAGEMENT, L.P. Director Neutral 52.5 - 0.00% -
Jul 18, 2024 5AM Partners VI, LLC 10% Owner Neutral 52.5 - 0.00% -
Jul 18, 2024 Miralles Gines Diego Director Neutral 52.5 - 0.00% -
Jul 18, 2024 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner Neutral 52.5 - 0.00% -
Jul 18, 2024 Stoppel Laura Director Neutral 52.5 - 0.00% -
Jul 18, 2024 GC Corp. 10% Owner Neutral 52.5 - 0.00% -
Jul 18, 2024 HOUGEN ELIZABETH L Director Neutral 52.5 - 0.00% -
Jul 18, 2024 DANIELS BRIAN Director Neutral 52.5 - 0.00% -
Jul 18, 2024 Raymon Heather SVP, Research and Development Neutral 52.5 - 0.00% -
Jul 18, 2024 Huh Yong-Jun Director Neutral 52.5 - 0.00% -
Jul 18, 2024 Bessen Laura Director Neutral 52.5 - 0.00% -
Jul 18, 2024 Graef Thorsten Chief Medical Officer Neutral 52.5 - 0.00% -
Jul 18, 2024 Krishnamohan Neha CFO Neutral 52.5 - 0.00% -
Jul 18, 2024 Horan Christopher Chief Tech Operations Officer Neutral 52.5 - 0.00% -
Jul 18, 2024 Bush Jennifer COO Neutral 52.5 - 0.00% -
Jul 18, 2024 Aslan Fred CEO Neutral 52.5 - 0.00% -